Use of electronic cigarettes for smoking cessation
EU CTIS ID: 2024-518135-10-00
What this study is testing
To assess the efficacy of electronic cigarettes containing nicotine (ECwN) comparatively to an EC without nicotine (ECwoN) and to a reference, licensed smoking cessation medication: varenicline.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Smokers smoking at least 10 cigarettes/day (factory made or roll-your-own) in the past year
- Aged 18 to 70 years
- Motivated to quit defined as a score > 5 on a visual rating scale ranging from 0 (not motivated at all) to 10 (extremely motivated)
You likely can't join if
- any unstable disease condition within the last 3 months defined by the investigator as major change in symptoms or treatments, such as : see protocol
- any life threatening condition with life-expectancy of less than 3 months
- alcohol use disorder defined as a score ? 10 on the AUDIT-C questionnaire
- abuse of or dependence on illegal drugs in the last 6 months revealed by the medical history
- regular use of tobacco products other than cigarettes
- current or previous (last 6 months) use of electronic cigarette
See the full eligibility criteria
- Smokers smoking at least 10 cigarettes/day (factory made or roll-your-own) in the past year
- Aged 18 to 70 years
- Motivated to quit defined as a score > 5 on a visual rating scale ranging from 0 (not motivated at all) to 10 (extremely motivated)
- any unstable disease condition within the last 3 months defined by the investigator as major change in symptoms or treatments, such as : see protocol
- any life threatening condition with life-expectancy of less than 3 months
- alcohol use disorder defined as a score ? 10 on the AUDIT-C questionnaire
- abuse of or dependence on illegal drugs in the last 6 months revealed by the medical history
- regular use of tobacco products other than cigarettes
- current or previous (last 6 months) use of electronic cigarette
- pregnant women
- breastfeeding women
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.